Patho Flashcards
NSAIDs
- Indication
- DO NOT prevent or slow joint destruction
- Provide some sx relief, not appropriate for monotherapy & should only be used in conjunction w/ DMARDs
Corticosteroids
- Indication
- Potent anti-inflammatory agents that can slow down the progression of joint damage in RA
- Due to its SEs when use in long term
=> Reserved for brief periods of active disease
Bridge therapy use until DMARDS take effect
- Low dose Prednisone 5-10mg
Rayos
- Formula
- Administration
Prednisone Delayed-Release
- F: 1, 2, 5 mg tab
- Take w/ FOOD = incr absorption
- The shell breaks open= releases ~ 4H after adm
=> RayOs => O => take w/ FOOD
Ridaura
- Form
- Dose
- SEs
- Monitor
Auranofin = gold salt
- Form: PO
- Dose: 3mg BID or 6mg QD PO
- SEs: Itchy rash, mouth ulcers, diarrhea, flushing, vasodilation
Monitoring
- CBC Q3M
- UA Q3M for PO
Myochrysine
- Indication
- Route of adm
- SEs
- Monitoring
Gold sodium thiomalate = gold salt
- Indication: RA
- Dose: IM
SEs IM - Pruritic rash 20%, Stomatitis - Proteinuria - BMS/Leucopenia, thrombocytopenia, anemia - Nitroid rxn, flushing (vasodilation) - HypoTN => tachycardia => gOld => O => hypOtn
Monitoring
- CBC Q3M
- UA Q3M for PO
Rheumatrex
Trexall
- Form
- Indications
Methotrexate
- Form: PO
Indications:
- Ectopic pregnancy
- Psoriasis
- Chemotherapy
- RA
Arava
Leflunomide
Imuran
Azathioprine
Cuprimine
D- Penicillamine
Plaquenil
Hydroxychloroquine
Azulfidine
Azulfidine EN-tabs
Sulfazine
Sulfazine EC
- Indication
Sulfasalazine
- UC
- RA
Xeljanz
Tofacitinib
Toe fa SYE tin nib
Kineret
- Indication
Anakinra
- Indication: RA, Neonatal-onset multisystem inflammatory disease (NOMID)
Enbrel
Etanercept
Remicade
Infliximab
Humira
Adalimumab
A da LIM YOO mab
Simponi
Golimumab
Cimzia
Certolizumab
Cer to LIZ u mab
Orencia
Abatacept
Rituximab
Rituxan
Actemra
Tocilizumab
Golimumab
- Form:
Simponi-SC
Simponi Aria - IV
Methotrexate
- MOA
=> what it’s is
=> Work on which phase - Indications
MOA
- Antimetabolite chemotherapy (cell cycle specific)
- S-phase toxin (DNA synthesis phase)
- Folic acid structural analog
- Completely inhibits dihydrofolate (DHF) reductase
- Inhibits de novo pyrimidine synthesis
Indications
- Cancer Chemo
- Ectopic pregnancy (terminate pregnancy)
- Psoriasis
- RA
Methotrexate
- Dosing for RA
=> Initial
=> Max
=> Rec take supplement
Rheumatrex, Otrexup, Trexall
Dosing - Initial: 7.5mg PO single dose - 2.5mg PO Q12H x 3 doses given as a course QW - Max: 20mg/W - Supplement: 1mg/d Folate => 1mg is Rx. 0.4 and 0.8 mg is OTC
Methotrexate
- SEs
- Monitor
SEs
- Oral ulcer & stomatitis
- GI = N/diarrhea => most common
- Hepatotoxicity
- Renal
- Pulmonary fibrosis (CXR)
- Hypersensitivity pneumonitis: dry cough, fever, dyspenia. If so, stop MTX, exclude infection and start corticosteroids
- Myelo-supression/thombo-cytopenia: minimal compare to imuran, cytoxin, sandiummune
Monitor => obtain baseline
- CBC (WBC & plt Q4W)
- CXR
- LFT (Q3-4M)
- Renal fxn
Methotrexate
- Absolute CI
- Relative CI
Absolute CI
- Preg Cat X and lactating W
- Renal insuffiency SrCr > 1.5
- Pleural effusion
- Active stomatitis
- Diarrhea or any infection
- Immuno-deficiency
Relative CI
- Alcohol use or liver disease
- Age > 70 => as pt age, renal decre
Methotrexate
- Antidote
- Leucovorin
Leflunomide
- MOA
- Dose
- ADEs
- Monitor
=> How long?
Arava
MOA
- Inhibits dihydroorotate dehydrogenase
- Inhibitor of T-cell activation and proliferation
Dose
- LD: 100 mg PO QD x 3d
- MD: 10-20mg PO QD
ADEs
- Nausea
- Alopecia
- Increase LFT (CI in imp liver fxn)
Monitor:
- LFT: ALT/ALT QM x 6M.
Then Q8W thereafter (2Months)
- CBC